Evaluation of cases with congenital muscular dystrophy Original Article

Year 2009, Volume: 44 Issue: 1, 3 - 8, 01.03.2009

Uluç Yiş Gökhan Uyanık Semra Hız Kurul Handan Çakmakçı Erdener Özer Eray Dirik Ute Hehr Deborah J. Morris-rosendahl

Abstract

Aim: The aim of this study is to evaluate clinical and radiological features of our cases with congenital muscular dystrophy nbsp; nbsp; Material and Method: The data of cases who were diagnosed with congenital muscular dystrophy in the Division of Pediatric Neurology of Dokuz Eylül University School of Medicine between July 2005 and July 2008 were analysed retrospectively Results: A total of 13 cases were evaluated Among the 13 cases seven 53 were boys and six 47 were girls Seven patients 53 were in the alfa dystroglycanopathy group five patients 38 were in collagen VI related congenital muscular dystrophy group and one patient 9 was in “rigid spine” group The mean age of cases with alfa dystroglycanopathy and collagen VI related congenital muscular dystrophy were 3 57±2 92 0 5 7 and 10 83±5 67 1 16 years respectively In alfa dystroglycanopathy group five cases 71 had eye involvement and six cases 85 had developmental malformations of the central nervous system All cases had brainstem hypoplasia and six cases 85 had cerebellar cysts In collagen VI related congenital muscular dystrophy group the main complaints were retardation in motor mile stones nbsp; contractures in proximal joints and hyperlaxicity in distal joints The most important clinical features in the case diagnosed with “rigid spine” syndrome were severe scoliosis and muscle atrophy Conclusions: The clinical features of congenital muscular dystrophies are heterogenous and increase in number of cases diagnosed as congenital muscular dystrophy should give an opportunity to determine the incidence of different types of congenital muscular dystrophies in our country nbsp; Turk Arch Ped 2009; 44: 23 8 Key words: Alfa dystroglycan collagen VI congenital muscular dystrophy muscle atrophy scoliosis

Keywords

-

Konjenital müsküler distrofili hastalarımızın değerlendirilmesi Orijinal Araştırma

Abstract

Amaç: Bu çalışmada konjenital müsküler distrofi tanısı ile izlenen hastalarımızın klinik ve radyolojik bulgularının değerlendirilmesi amaçlanmıştır Gereç ve Yöntem: Temmuz 2005 ve Temmuz 2008 arasında Dokuz Eylül Üniversitesi Tıp Fakültesi Çocuk Nöroloji Bilim Dalı’nda konjenital müsküler distrofi tanısı alan olguların dosya kayıtları geriye dönük olarak incelendi Bulgular: Çalışmaya alınan 13 hastanın yedisi 53 erkek altısı 47 kızdı Yedi hasta 53 alfa distroglikanopati beş hasta 38 kollajen VI ile ilişkili konjenital müsküler distrofi bir hasta 9 “rigid spine” sendromu grubunda yer almaktaydı Alfa distroglikanopati ve kollajen VI ile ilişkili konjenital müsküler distrofili hastaların ortalama yaşı sırasıyla 3 57±2 92 0 5 7 ve 10 83±5 67 1 16 yıldı Alfa distroglikanopati grubunda beş olguda 71 göz tutulumu altı olguda 85 merkezi sinir sistemi gelişimsel anomalisi vardı Olguların tümünde beyin sapı hipoplazisi altısında 85 beyincikte kistler vardı Kollajen VI ile ilişkili konjenital müsküler distrofi grubunda en sık başvuru yakınması motor gelişimde gerilik proksimal eklem kontraktürleri ve değişen derecelerde distal eklem hiperlaksisitesiydi “Rigid spine” sendromu tanısı alan hastada ise en önemli klinik bulgular ileri derecede skolyoz ve kas atrofisiydi Çıkarımlar: Konjenital müsküler distrofilerde klinik bulgular değişken olup ülkemizde tanı alan konjenital müsküler distrofili olguların artması değişik tiplerin görülme sıklığının saptanmasına olanak sağlayacaktır Türk Ped Arş 2009; 44: 23 8 Anahtar kelimeler: Alfa distroglikan kas atrofisi kollajen VI konjenital müsküler distrofi skolyoz

Keywords

Alfa distroglikan, kas atrofisi, kollajen VI, konjenital müsküler distrofi, skolyoz

References

• Voit T. Congenital muscular dystrophies. In: Karpati G, Hilton-Jo- nes D, Griggs RC, (eds). Disorders of voluntary muscle. 7th ed. Cambridge, UK: Press Syndicate of the University of Cambridge, 2001: 503-24.
• Neuromuscular disorders: gene location. Neuromuscul Disord 2006;16: 64-90.
• Brockington M, Yuva Y, Prandini P, et al. Mutations in the fukutin- related protein gene (FKRP) identify limb girdle muscular dystro- phy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001; 10: 2851-9.
• Brockington M, Blake DJ, Prandini P, et al. Mutations in the fuku- tin-related protein gene (FKRP) cause a form of congenital mus- cular dystrophy with secondary laminin alpha2 deficiency and ab- normal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001; 69: 1198-209.
• Darin N, Kimber E, Kroksmark AK, Tulinius M. Multiple congenital contractures: birth prevalence, etiology, and outcome. J Pediatr 2002; 140: 61-7.
• Mostacciuolo ML, Barbujani G, Armani M, Danieli GA, Angelini C. Genetic epidemiology of myotonic dystrophy. Gen Epidemiol 1987; 4: 289-98.
• Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord 2004; 14: 635-49.
• Peat RA, Smith JM, Compton AG, et al. Diagnosis and etiology of congenital muscular dystrophy. Neurology 2008; 71: 312-21.
• Talim B, Akcoren Z, Haliloğlu G, et al. Frequency of different forms of congenital muscular dystrophy in a referral center. Neuromus- cul Disord 2008; 18: 724-833.
• Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC. Defecti- ve glycosylation in muscular dystrophy. Lancet 2002; 360: 1419-21.
• Cohn RD. Dystroglycan: important player in skeletal muscle and beyond. Neuromuscul Disord 2005; 15: 207-17.
• Martin PT. The dystroglycanopathies: the new disorders of O-lin- ked glycosylation. Semin Pediatr Neurol 2005; 12: 152-8.
• Muntoni F. Journey into muscular dystrophies caused by abnor- mal glycosylation. Acta Myol 2004; 23: 79-84.
• Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989; 32: 195-210.
• Yis U, Uyanık G, Kurul S, et al. A case of Walker Warburg syndro- me resulting from a homozygous POMT1 mutation. Eur J Pediatr Neurol 2007; 11: 46-9.
• Toda T, Kobayashi K, Kondo-Iida E, Sasaki J, Nakamura Y. The Fukuyama congenital muscular dystrophy story. Neuromuscul Disord 2000; 10: 153-9.
• Nakanishi T, Sakauchi M, Kaneda Y, et al. Cardiac involvement in Fukuyama-type congenital muscular dystrophy. Pediatrics 2006; 117: 1187-92.
• Silan F, Yoshioka M, Kobayashi K, et al. A new mutation of the fu- kutin gene in a non-Japanese patient. Ann Neurol 2003; 53: 392-6.
• Godfrey C, Clement E, Mein R, et al. Refining genotype phenoty- pe correlations in muscular dystrophies with defective glycosyla- tion of dystroglycan. Brain 2007; 130: 2725-35.
• De Bernabe DB, Van Bokhoven H, Van Beusekom E, et al. A ho- mozygous nonsense mutation in the fukutin gene causes a Wal- ker Warburg syndrome phenotype. J Med Gen 2003; 40: 845-8.
• Cotarelo RP, Valero MC, Prados B, et al. Two new patients bea- ring mutations in the fukutin gene confirm the relevance of this gene in Walker Warburg syndrome. Clin Genet 2008; 73: 139-45.
• Cormand B, Pihko H, Bayes M, et al. Clinical and genetic distinc- tion between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 2001; 56: 1059-69.
• Topaloğlu H, Brockington M, Yuva Y, et al. FKRP gene mutations cause congenital muscular dystrophy, mental retardation and ce- rebellar cysts. Neurology 2003; 60: 988-92.
• Ullrich O. Kongenitale atonisch-sklerotische muskeldystrophie, ein weiterer typus der heredodegeneration erkrankungen des neuro- muskularen systems. Z Ges Neurol Psychiat 1930; 126: 171-201.
• Demir E, Sabatelli P, Allamand V, et al. Mutations in COL6A3 cau- se severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet 2002; 70: 1446-58.
• Hessle H, Engvall E. Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies. J. Biol. Chem. 1984; 259: 3955-61.
• Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F. Conge- nital muscular dystrophy: molecular and cellular aspects. Cell Mol Life Sci 2005; 62: 809-23.
• Lisi MT, Cohn RD. Congenital muscular dystrophies: New aspects of an expanding group of disorders. Biochim Biophys Acta 2007; 1772: 159-172.
• Petit N, Lescure A, Rederstorff M, et al. Selenoprotein N: an en- doplasmic reticulum glycoprotein with an early developmental ex- pression pattern. Hum Mol Genet 2003; 12: 1045-53.
• Mercuri E, Talim B, Moghadaszadeh B, et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromus- cul Disord 2002; 12: 631-8.